BiomX Inc.

08/04/2022 | Press release | Distributed by Public on 08/04/2022 09:27

BiomX Announces Publication in Cell of Research Demonstrating Proof-of-Concept Assessment of Orally Administered Phage Treatment in Preclinical Model of Inflammatory Bowel Disease